Daniel M Bollag - Net Worth and Insider Trading
Daniel M Bollag Net Worth
The estimated net worth of Daniel M Bollag is at least $3 Million dollars as of 2025-01-12. Daniel M Bollag is the Sr. VP, Reg. Affairs & Quality of ARIAD Pharmaceuticals Inc and owns about 129,404 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $3 Million. Daniel M Bollag is also the See Remarks of Ocular Therapeutix Inc and owns about 42,100 shares of Ocular Therapeutix Inc (OCUL) stock worth over $345,641. Details can be seen in Daniel M Bollag's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel M Bollag has not made any transactions after 2018-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel M Bollag
Daniel M Bollag Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel M Bollag owns 2 companies in total, including Ocular Therapeutix Inc (OCUL) , and ARIAD Pharmaceuticals Inc (ARIA) .
Click here to see the complete history of Daniel M Bollag’s form 4 insider trades.
Insider Ownership Summary of Daniel M Bollag
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
OCUL | Ocular Therapeutix Inc | 2018-12-06 | SVP,Reg Affairs,Pharma & Qual |
ARIA | ARIAD Pharmaceuticals Inc | 2017-02-16 | Sr. VP & Reg. Affairs & Quality |
Daniel M Bollag Latest Holdings Summary
Daniel M Bollag currently owns a total of 2 stocks. Among these stocks, Daniel M Bollag owns 129,404 shares of ARIAD Pharmaceuticals Inc (ARIA) as of January 9, 2017, with a value of $3 Million and a weighting of 89.98%. Daniel M Bollag also owns 42,100 shares of Ocular Therapeutix Inc (OCUL) as of December 6, 2018, with a value of $345,641 and a weighting of 10.02%.
Latest Holdings of Daniel M Bollag
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARIA | ARIAD Pharmaceuticals Inc | 2017-01-09 | 129,404 | 23.99 | 3,104,402 |
OCUL | Ocular Therapeutix Inc | 2018-12-06 | 42,100 | 8.21 | 345,641 |
Holding Weightings of Daniel M Bollag
Daniel M Bollag Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel M Bollag has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 32,000 shares on January 9, 2017, which brought Daniel M Bollag around $760,960.
According to the SEC Form 4 filings, Daniel M Bollag has made a total of 0 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years. The most-recent trade in Ocular Therapeutix Inc is the acquisition of 17,400 shares on December 6, 2018, which cost Daniel M Bollag around $100,224.
Insider Trading History of Daniel M Bollag
- 1
Daniel M Bollag Trading Performance
GuruFocus tracks the stock performance after each of Daniel M Bollag's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel M Bollag is 34.02%. GuruFocus also compares Daniel M Bollag's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel M Bollag within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel M Bollag's insider trading performs compared to the benchmark.
Performance of Daniel M Bollag
Daniel M Bollag Ownership Network
Ownership Network List of Daniel M Bollag
Ownership Network Relation of Daniel M Bollag
Daniel M Bollag Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Daniel M Bollag is the SVP,Reg Affairs,Pharma & Qual of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Financial Officer Donald Notman .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Daniel M Bollag made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 63,186 shares made by Pravin Dugel , a net sale of 31,480 shares made by Antony C. Mattessich , and a net sale of 2,897 shares made by .
In summary, during the past 3 months, insiders sold 28,339 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 28,339 shares. During the past 18 months, 163,603 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,312,209 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Daniel M Bollag Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel M Bollag. You might contact Daniel M Bollag via mailing address: C/o Ariad Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge Ma 02139.